Schmid John P.
- SEC CIK
- 0001478916
In the past year, 1 open-market purchase filing worth $96.0K and 1 sale filing worth $1.16M.
Current role at each company
- BLSM BlossomHill Therapeutics, Inc.Directoras of Aug 10, 2026
- ANAB Anaptysbio, IncDirectoras of Jun 17, 2026
- TRAX First Tracks Biotherapeutics, Inc.Directoras of Jun 17, 2026
- DSGN Design Therapeutics, Inc.Directoras of Jun 11, 2026
- BBOT BridgeBio Oncology Therapeutics, Inc.Other: Former Directoras of Aug 11, 2025
Show 2 more companies
- PSTX Poseida Therapeutics, Inc.Directoras of Jan 8, 2025
- XERS Xeris Biopharma Holdings, Inc.Directoras of Aug 13, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $96.0K
- 1 filing
- Sold
- $1.16M
- 1 filing
- Net
- −$1.06M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Schmid John P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BLSM BlossomHill Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)6:35 PM ET | Aug 10 | Same day | Schmid John P.Director | PPurchase | +6.00K | $16.00 | +$96.0K | New position6.00K after |
ANAB Anaptysbio, Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 (view filing) | Mar 30 | 2 days | Schmid John P.Director | SSale | −20.6K | $56.11 | −$1.16M | −39.5%31.6K after | 3 lots |
XERS Xeris Biopharma Holdings, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2024 (view filing) | Aug 12 | 1 day | Schmid John P.Director | PPurchase | +4.51K | $2.25 | +$10.2K | +21.8%25.2K after | |
| Aug 12, 2024 (view filing) | Aug 9 | 3 days | Schmid John P.Director | PPurchase | +4.29K | $2.37 | +$10.2K | +26.1%20.7K after | |
| May 10, 2024 (view filing) | May 10 | Same day | Schmid John P.Director | PPurchase | +5.40K | $1.91 | +$10.3K | +49.1%16.4K after | |
| Mar 14, 2024 (view filing) | Mar 14 | Same day | Schmid John P.Director | PPurchase | +4.50K | $2.16 | +$9.72K | +69.2%11.0K after | |
| Nov 17, 2023 (view filing) | Nov 16 | 1 day | Schmid John P.Director | PPurchase | +6.50K | $1.51 | +$9.81K | New position6.50K after |
DSGN Design Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 (view filing) | Mar 22-25 | 3 days | Schmid John P.Director | PPurchase | +27.0K | $3.70 | +$99.8K | New position27.0K after | 2 lots |